Our Mission

The Journal of Clinical Intensive Care and Medicine (JCICM) strives to promote high-quality, evidence-based research and clinical practice in critical care and intensive medicine. Our mission is to provide a reliable platform where researchers, clinicians, and healthcare providers can exchange knowledge and contribute to improving the survival and quality of life of critically ill patients worldwide.

Scope of Coverage

The journal accepts original research articles, reviews, meta-analyses, case studies, guidelines, and commentaries covering diverse areas within critical and intensive care. These include but are not limited to:

  • Clinical management of critically ill adults, children, and neonates.
  • Advances in emergency medicine and trauma care.
  • Respiratory support, mechanical ventilation, and innovative airway management strategies.
  • Sepsis, systemic inflammatory response, and antimicrobial resistance in critical care.
  • Cardiac arrest, acute coronary syndromes, and advanced cardiovascular interventions.
  • Neurological critical care including traumatic brain injury and neurodegenerative conditions.
  • Renal replacement therapies and management of multi-organ dysfunction.
  • Surgical intensive care and perioperative critical care medicine.
  • Ethics, communication, and decision-making in end-of-life care.
  • Medical technology, monitoring devices, and digital health solutions for ICUs.

Global and Multidisciplinary Perspective

JCICM recognizes the global nature of intensive care medicine. Contributions from diverse geographic and cultural contexts are welcomed to provide a comprehensive understanding of patient management in varied resource settings. The journal encourages multidisciplinary submissions involving anesthesiologists, intensivists, surgeons, cardiologists, neurologists, pediatricians, infectious disease specialists, nurses, pharmacists, physiotherapists, and allied healthcare workers.

Innovations and Emerging Areas

The journal actively supports publications on innovative therapies and future directions in intensive care medicine. Submissions exploring artificial intelligence in patient monitoring, precision medicine, biomarkers for early disease detection, tele-intensive care systems, and novel pharmacological or interventional strategies are especially encouraged.

Commitment to Ethical Standards

All published work must adhere to international ethical standards including COPE, ICMJE, and WAME recommendations. Research involving human or animal subjects requires explicit ethical approval, and clinical trials must follow recognized registration protocols. JCICM promotes transparency, reproducibility, and responsible research dissemination.

Author Benefits

  • Rapid review and timely publication to ensure urgent findings reach clinicians quickly.
  • Global visibility through indexing and open access dissemination.
  • Permanent DOI and archiving for long-term citation and accessibility.
  • Constructive editorial feedback to enhance manuscript quality.

FAQs

What types of manuscripts are most encouraged? Research with direct clinical relevance, interdisciplinary collaboration, and innovative treatment strategies.

Does JCICM consider negative results? Yes, studies with negative or neutral results that advance scientific understanding are welcomed.

How broad is the scope? As long as the manuscript addresses intensive care, emergency medicine, or related multidisciplinary areas, it fits within our scope.